Legal & General Group PLC Astrazeneca PLC Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Legal & General Group PLC holds 808,547 shares of AZN stock, worth $59.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
808,547
Previous 909,176 11.07%
Holding current value
$59.5 Million
Previous $70.8 Million 25.22%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$63.2 - $79.58 $6.36 Million - $8.01 Million
-100,629 Reduced 11.07%
808,547 $53 Million
Q3 2024

Nov 14, 2024
SELL
$76.67 - $87.62 $1.21 Million - $1.38 Million
-15,796 Reduced 1.71%
909,176 $70.8 Million
Q2 2024

Aug 14, 2024
SELL
$66.81 - $80.83 $1.1 Million - $1.33 Million
-16,503 Reduced 1.75%
924,972 $72.1 Million
Q1 2024

Jul 01, 2024
BUY
$61.03 - $69.57 $496,051 - $565,464
8,128 Added 0.87%
941,475 $63.8 Million
Q1 2024

May 14, 2024
SELL
$61.03 - $69.57 $943,523 - $1.08 Million
-15,460 Reduced 1.63%
933,347 $63.2 Million
Q4 2023

Feb 15, 2024
SELL
$61.89 - $69.28 $2.74 Million - $3.07 Million
-44,323 Reduced 4.46%
948,807 $63.9 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $277,104 - $306,374
-4,273 Reduced 0.43%
993,130 $67.3 Million
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $17.4 Million - $18.9 Million
-249,401 Reduced 20.0%
997,403 $71.4 Million
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $5.98 Million - $6.78 Million
-94,732 Reduced 7.06%
1,246,804 $86.5 Million
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $6.66 Million - $8.65 Million
-122,869 Reduced 8.39%
1,341,536 $91 Million
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $39.3 Million - $101 Million
-741,455 Reduced 33.61%
1,464,405 $80.3 Million
Q2 2022

Aug 22, 2022
SELL
$59.26 - $71.14 $36.8 Million - $44.1 Million
-620,559 Reduced 21.96%
2,205,860 $146 Million
Q1 2022

May 16, 2022
SELL
$55.72 - $67.12 $68.1 Million - $82 Million
-1,222,429 Reduced 30.19%
2,826,419 $187 Million
Q4 2021

Feb 14, 2022
SELL
$54.02 - $63.83 $77.1 Million - $91.1 Million
-1,427,165 Reduced 26.06%
4,048,848 $236 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $304 Million - $333 Million
5,476,013 New
5,476,013 $329 Million
Q4 2020

Feb 12, 2021
SELL
$48.52 - $58.02 $29.6 Million - $35.4 Million
-610,660 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$53.07 - $61.1 $32.4 Million - $37.3 Million
610,660 New
610,660 $33.5 Million
Q4 2019

Feb 13, 2020
SELL
$42.46 - $50.46 $10.2 Million - $12.1 Million
-240,448 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$40.12 - $45.47 $9.65 Million - $10.9 Million
240,448 New
240,448 $10.7 Million

Others Institutions Holding AZN

# of Institutions
1,351
Shares Held
489M
Call Options Held
5.88M
Put Options Held
4.1M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $228B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email